1st International Lung Cancer Symposium – 2015
Theme: Advanced Early Diagnosis and Early Therapy of Lung Cancer
August 8-9, 2015 Place: Beijing, China
Registration Day Time: 8:30-22:00 (Whole day), Aug. 7, 2015 Place: Lobby of Conference Hotel |
Group Photo for All Delegates and Speakers Day 1: Time: 8:40-8:55 (Morning), Aug. 8, 2015 Place: TBC |
Session 1: Prevention and Epidemiology of Lung Cancer Day 1: Time: 8:30-10:40 (Morning), Aug. 8, 2015 Conference Room: 4-1 |
|
9:00-9:20 |
Session Introduction Session Chair: Available (Session 1, Session 2) |
9:20-9:40 |
Title: Chemoprevention of Lung Cancer: What Lessons We Learned Dr. Xiang-Dong Wang, Director and Senior Scientist, Nutrition and Cancer Biology Laboratory, Professor, Tufts University, USA |
9:40-10:00 |
Title: Advances in Lung Cáncer Prevention in México Dr. Elma Correa-Acevedo, Clinic of Thoracic Oncology, National Cancer Institute of Mexico (INCan), Mexico |
10:00-10:20 |
Title: Clinical Quality Registries: Driving Improvement in Care in Lung Cancer Dr. Rob G. Stirling, Department of Allergy Immunology and Respiratory Medicine, The Alfred Hospital, Monash University, Australia |
10:20-10:40 | Speech Opportunity Available |
Session 2: Basic Research of Lung Cancer Day 1: Time: 10:40-12:20 (Morning), Aug. 8, 2015 Conference Room: 4-1 |
|
10:40-11:00 |
Title: Using Tumor ATM Status to Direct Precision Medicine for Advanced Non-Small Cell Lung Cancer Dr. Gwyn Bebb, Medical Oncologist, Tom Baker Cancer Centre, University of Calgary, Canada |
11:00-11:20 |
Title: Correlation of EGFR Expression, Gene Copy Number and Clinicopathological Status in NSCLC Dr. Rania Gaber, Department of Pathology, Faculty of Medicine, University of Alexandria, Egypt |
11:20-11:40 |
Title: TBD Dr. Eric S. Kim, Assistant Professor, Division of Hematology and Oncology, University of Rochester Medical Center, USA |
11:40-12:00 |
Title: TBD Dr. Krishna P. Gupta, Indian Institute of Toxicology Research Carcinogenesis Division, India |
12:00-12:20 | Speech Opportunity Available |
Session 3: Diagnostics and Clinical Management of Lung Cancer Day 1: Time: 13:30-17:00 (Afternoon), Aug. 8, 2015 Conference Room: 4-1 |
|
13:30-13:40 |
Session Introduction Session Chair: Available (Session 3, Session 4) Session Co-chair: Available (Session 3, Session 4) |
13:40-14:00 |
Title: Clinical Implication of Molecular Profiling in Lung Cancer Dr. Zhaolin Xu, Professor, Department of Pathology, Dalhousie University, Canada |
14:00-14:20 |
Title: Lung Cancer Screening and NLST trial Dr. Gye Y Park, University of Illinois Hospital & Health Sciences System, USA |
14:20-14:40 | Speech Opportunity Available |
14:40-15:00 |
Title: Evaluation of Pulmonary Nodules: Clinical Practice Guidelines in China Dr. Chunxue Bai, Director, Shanghai Respiratory Research Institute, China, Professor, Fudan University, China |
15:00-15:20 |
Title: The Detection of Serum APE1 Protein and Its Significance in Diagnosis of Lung Cancer Dr. Dong Wang, Director and Professor, Daping Hospital, Third Military Medical University, China |
15:20-15:40 |
Title: Molecular Features Involved in TKI Response in NSCLC Patients without EGFR Mutations Dr. Paola Ulivi, Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Italy |
15:40-16:00 | Coffee Break |
16:00-16:20 |
Title: Clinical-Radiological Correlation of Lung Cancer Dr. Joel Oswaldo Ortega Estrada, Chest Physicians, European Respiratory Society, Mexico |
16:20-16:40 |
Title: Association Between Environmental Tobacco Smoke Exposure and Lung Cancer Susceptibility : Modification by Antioxidant Enzyme Genetic Polymorphisms Dr. Wafaa M. Ashour, Chest Diseases Department, Faculty of Medicine, Cairo University, Egypt |
16:40-17:00 |
Title: Molecular Diagnostics of Lung Cancer Dr. Enas Samir Nabih, Faculty of Medicine, Ain Shams University, Egypt |
Session 4: Drug Discovery and Therapeutics of Lung Cancer Day 1: Time: 17:00-18:20 (Afternoon), Aug. 8, 2015 Conference Room: 4-1 |
|
17:00-17:20 |
Title: A Vertically-Integrated Approach to Validate Biomarkers and Identify Novel Targets in Cancer Dr. Raj K. Batra,Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, USA |
17:20-17:40 |
Title: Immunotherapy of NSCLC Dr. Konstantinos N. Syrigos, Professor and Head, Oncology Unit, 3rd Dept of Medicine, Athens University School of Medicine, Sotiria General Hospital, Greece |
17:40-18:00 |
Title: Epigenetic Strategies for Precision Therapy of Lung Cancer Dr. David S. Schrump, Senior Investigator and Surgical Chief, Thoracic and GI Oncology Branch, CCR/NCI, USA |
18:00-18:20 | Speech Opportunity Available |
19:00-20:30 | Welcome Banquet |
Session 5: Radiotherapy of Lung Cancer Day 2: Time: 8:30-10:40 (Morning), Aug. 9, 2015 Conference Room: 4-1 |
|
8:30-8:40 |
Session Introduction Session Chair: Available (Session 5, Session 6) Session Co-chair: Available (Session 5, Session 6) |
8:40-9:00 |
Title: TBD Dr. Laurie Gaspar, Professor and Chair, Department of Radiation Oncology, University of Colorado at Denver and Health Sciences Center, USA |
9:00-9:20 |
Title: Ameliorating Normal Tissue Damage from Thoracic Radiotherapy Using Alternative Treatments Dr. Melpo Christofidou-Solomidou, Associate Professor, University of Pennsylvania Medical Center, USA |
9:20-9:40 | Speech Opportunity Available |
9:40-10:00 |
Title: TBD Dr. Guangying Zhu, Chair and Professor, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, China |
10:00-10:20 |
Title: Status of Lung Radiotherapy Resources in Pakistan Dr. Muhammad Nauman Usmani, Osaka University Graduate School of Medicine, Japan |
10:20-10:40 |
Title: Radiotherapy Combined with Target Therapy for NSCLC Dr. Jun Liang, Department of Radiation Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, China |
Session 6: Surgery and Supportive Care of Lung Cancer Day 2: Time: 10:40-12:20 (Morning), Aug. 9, 2015 Conference Room: 4-1 |
|
10:40-11:00 |
Title: TBD Dr. David S. Schrump, Surgical Chief, Thoracic Surgery Section, Thoracic and GI Oncology, Branch, CCR/NCI, National Institutes of Health, USA |
11:00-11:20 |
Title: TBD Dr. Daniela Molen, Assistant Professor of Surgery, Director, Robotic and Minimally Invasive Thoracic Surgery, Director of Thoracic Surgery, Johns Hopkins Bayview Medical Center, The Johns Hopkins University, USA |
11:20-11:40 |
Title: Developing Strategies for Improving Quality of Care in Lung Cancer Dr. Rob G. Stirling, Department of Allergy Immunology and Respiratory Medicine, The Alfred Hospital, Monash University, Australia |
11:40-12:00 | Speech Opportunity Available |
12:00-12:20 |
Title: Uniportal CVATS Segmentgectomy for Small Lung Cancer Dr. Zheng Wang, Statistical Editor, Department of Thoracic Surgery, Shenzhen People’s Hospital, Second Affiliated Hospital, Medical College of Ji’nan University, China |
Session 7: Advanced Technology of Lung Cancer Day 2: Time: 13:30-15:20 (Afternoon), Aug. 9, 2015 Conference Room: 4-1 |
|
13:30-13:40 |
Session Introduction Session Chair: Available (Session 7, Session 8, Session 9) Session Co-chair: Available (Session 7, Session 8, Session 9) |
13:40-14:00 |
Title: Thermal Ablation of Malignant Lung Tumors Dr. Thomas.Schneider, Department of Thoracic Surgery, St.Vincentius-Kliniken Karlsruhe, Germany |
14:00-14:20 | Speech Opportunity Available |
14:20-14:40 |
Title: TBD Dr. Vladimir Jurisic, Professor, School of Medicine, University of Kragujevac, Serbi |
14:40-15:00 |
Title: Advanced Biopsy Technology for Small Lung Nodules Dr. Guo Shu-liang, Professor, Department of Respiratory, First Affiliated Hospital of Chongqing Medical University, China |
15:00-15:20 |
Title: TBD Dr. Hong Wang, Department of Lung Cancer, Affiliated Hospital of Academy of Military Medical Sciences (307 Hospital of PLA), Beijing, China |
15:20-15:40 | Coffee Break |
Session 8: Prognostic of Lung Cancer Day 2: Time: 15:40-17:00 (Afternoon), Aug. 9, 2015 Conference Room: 4-1 |
|
15:40-16:00 |
Title: The Role of Metabolic Rumor Volume as a Prognostic Marker in Patients with Non-small Cell Lung Cancer Dr. Jose G. Bazan, Assistant Professor, Department of Radiation Oncology, The Ohio State University, Arthur G. James Comprehensive Cancer Center, USA |
16:00-16:20 |
Title: The Importance of Immunohistochemistry on the Prognosis of Lung Cancer Dr. Enoe Quinonez, Department of Anatomical Pathology, San Cecilio University Hospital, Spain |
16:20-16:40 | Speech Opportunity Available |
16:40-17:00 |
Title: FoxQ1 Overexpression Influences Poor Prognosis in NSCLC, Through Regulating EMT and Increasing Chemosensitivity Dr. Jianfei Huang, Department of Pathology, Affiliated Hospital of Nantong University, China |
Session 9: Tumor Associated with Lung Cancer Day 2: Time: 17:00-17:40 (Afternoon), Aug. 9, 2015 Conference Room: 4-1 |
|
17:00-17:20 |
Title: Designing Clinical Trials for New Targeted Therapies: Ways to Improve Strategy Dr. Sonia Macia, Hospital General de Elche, Spain |
17:20-17:40 | Speech Opportunity Available |